Drug Trial Radar · NCT04658173
Efficacy and Safety Profile of Remimazolam-alfentanil Combination for ERCP Sedation
Last checked: Nov 19, 2026Latest source record: Dec 20, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
1,000
Planned (sponsor's estimate)
Start
Dec 22, 2020
Primary completion
Oct 1, 2022
Study completion Oct 1, 2023
Sponsor
- Lead sponsor
- Tianjin Nankai HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 8, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Moderate to deep levels of sedation and analgesia are required for ERCP. Propofol-based sedation is simple, easy to use, and effective, but is not without cardiovascular and respiratory adverse effects. The combination of remimazolam and alfentanil has shown promising results for sedation in other similar scenarios. The aim of this study was to compare the efficacy and safety of a standard propofol-alfentanil regimen with a remimazolam-alfentanil combination.
Conditions
- Anesthesia
Interventions
remimazolam-alfentanil combinationDrug
Group remimazolam-alfentanil combination received 10 µg/kg alfentanil and 0.3mg/kg remimazolam over 30 seconds, followed by an infusion of remimazolam at 0.2 to 1 mg/kg/hr and alfentanil at 0 to 1ug/kg/min. In case of the sudden patient movement, and difficulty in maneuvering the endoscope, remimazolam 0.1mg/kg was used in the form of bolus, as rescue drugs, and alfentanil 5ug/kg when additional analgesia is needed
propofol-alfentanil combinationDrug
Group propofol-alfentanil combination received 10 µg/kg alfentanil and 1 mg/kg propofol over 30 seconds followed by an infusion of propofol at 2 to 6 mg/kg/hr. In case of the sudden patient movement, and difficulty in maneuvering the endoscope, propofol 0.5 mg/kg was used in the form of bolus, as rescue drugs,and alfentanil 5ug/kg when additional analgesia is needed
Primary outcomes
What the sponsor says the trial is designed to measure.
- The number of hypoxiaTime frame: 1 day
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Tianjin Nankai Hospital
Tianjin, Tianjin Municipality, China · Recruiting
Tianjin NanKai hospital
Tianjin, Tianjin Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.